Evidence map›Paper›PMID 31063243›Full record

ArticleInternational wound journal2019

Release of sodium pyruvate from sacral prophylactic dressings: A computational model.

Ayelet Levy, Jan Kottner, Amit Gefen

Open access · bronzeAbstract read
In one paragraph

Article in International wound journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ayelet LevyDepartment of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
Jan KottnerCharité-Universitätsmedizin Berlin, Department of Dermatology and Allergy, Clinical Research Center for Hair and Skin Science, Berlin, Germany.
Amit GefenDepartment of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.ORCID https://orcid.org/0000-0002-0223-7218
Tel Aviv University · ILClinical Research Center for Hair and Skin Science · DE

Funding

Israeli Ministry of Science, TechnologySpace in the Third Age Program 3-12804
6 · The paper itself

Abstract

The use of sacral dressings for pressure ulcer prevention is growing rapidly. In addition to their passive biomechanical role in pressure and shear reduction, in the near future, prophylactic dressings may also provide active tissue protection by releasing preventive agents or drugs into skin and deeper tissues. We investigated delivery of sodium pyruvate (NaPy) from an active dressing to potentially protect the sacral skin and underlying tissues in addition. We used four finite element model variants describing different skin roughness levels to determine time profiles of NaPy diffusion from the dressing into the skin layers. The NaPy concentrations for the different modelled cases stabilised after 1 to 6.5 hours from the time of application of the dressings, at 1% to 3% of the NaPy concentration in the dressing reservoir, which is considered potent. We conclude that prophylactic sacral dressings have the potential to deliver NaPy into skin and subdermally, to potentially increase soft tissue tolerance to sustained bodyweight-caused cell and tissue deformations. The time durations to achieve the steady-state potent NaPy dermal concentrations are clinically feasible, for example, for preparation of patients for surgery or for use in intensive care units.

Indexed as

BandagesSkinfold ThicknessAdultAgedAged, 80 and overAnti-Bacterial AgentsComputer SimulationFemaleHumansMaleMiddle AgedPressure UlcerPyruvatesSacrococcygeal RegionAnti-Bacterial AgentsPyruvatescomputational simulationspressure ulcer preventionprophylactic dressingssodium pyruvate

Identifiers

PMID31063243
PMCPMC7948793
OpenAlexW2944241079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.